Mutations of the catenin-β gene (CTNNB1), a downstream effector of the wnt signaling pathway that has been postulated to be involved in DM carcinogenesis, have been identified in the pilomatricomas of patients with DM1 [38,52]. Here, CTNNB1 is linked to dermatomyositis.